https://pmc.ncbi.nlm.nih.gov/articles/PMC8634828/
Heterogeneity in NECTIN4 expression across molecular subtypes of urothelial cancer mediates...
Enfortumab vedotin (EV) is an antibody-drug conjugate (ADC) targeting NECTIN4 (encoded by the PVRL4/NECTIN4 gene) approved for treatment-refractory metastatic...
molecular subtypesurothelial cancerheterogeneityexpressionacross
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2022.958082/full
Frontiers | Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for...
Background: Chimeric antigen receptor T (CAR-T) cell therapy has made significant advances for hematological malignancies, but encounters obstacles in the tr...